Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Revenue | $275,091 | $237,503 | $290,574 | $240,373 |
| % Growth | 15.8% | -18.3% | 20.9% | – |
| Cost of Goods Sold | $105,671 | $91,664 | $129,500 | $92,786 |
| Gross Profit | $169,420 | $145,838 | $161,075 | $147,587 |
| % Margin | 61.6% | 61.4% | 55.4% | 61.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $136,890 | $122,777 | $124,228 | $119,290 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $136,890 | $122,777 | $124,228 | $119,290 |
| Operating Income | $32,530 | $23,062 | $36,847 | $28,297 |
| % Margin | 11.8% | 9.7% | 12.7% | 11.8% |
| Other Income/Exp. Net | $10,108 | $2,912 | $23,374 | $14,081 |
| Pre-Tax Income | $42,638 | $25,974 | $60,221 | $42,378 |
| Tax Expense | $11,283 | $7,906 | $6,720 | $11,080 |
| Net Income | $30,447 | $17,567 | $52,579 | $30,633 |
| % Margin | 11.1% | 7.4% | 18.1% | 12.7% |
| EPS | 0.11 | 0.06 | 0.18 | 0.11 |
| % Growth | 82.7% | -66.6% | 63.6% | – |
| EPS Diluted | 0.11 | 0.06 | 0.18 | 0.1 |
| Weighted Avg Shares Out | 288,242 | 291,924 | 292,920 | 291,738 |
| Weighted Avg Shares Out Dil | 288,634 | 292,194 | 292,920 | 293,322 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,282 | $3,412 | $3,740 | $4,774 |
| Interest Expense | $55 | $14 | $52 | $0 |
| Depreciation & Amortization | $12,341 | $11,579 | $11,882 | $10,180 |
| EBITDA | $55,041 | $37,580 | $72,162 | $52,524 |
| % Margin | 20% | 15.8% | 24.8% | 21.9% |